Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 1 12Phase NA 4Phase 3 3Phase 4 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Renal Cell 10Breast Neoplasms 5Sarcoma 2Prostatic Neoplasms 2Melanoma 2Gastrointestinal Stromal Tumors 2Urinary Bladder Neoplasms 1Solitary Fibrous Tumors 1Solid Tumors Refractory to Standard Therapy 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Osteosarcoma 1Neoplasms 1Neoplasm Metastasis 1Leukemia, Myeloid, Acute 1Leiomyosarcoma 1Kidney Neoplasms 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangioendothelioma, Epithelioid 1Hemangioendothelioma 1Fatigue 1Colorectal Neoplasms 1Chondrosarcoma, Extraskeletal Myxoid 1Chondrosarcoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 44Nivolumab 29Gemcitabine 28Paclitaxel 19Cisplatin 18Ipilimumab 15Carboplatin 14Cyclophosphamide 13Capecitabine 12Dexamethasone 10Bevacizumab 10cemiplimab 9Irinotecan 9Docetaxel 9Albumin-Bound Paclitaxel 9130-nm albumin-bound paclitaxel 9spartalizumab 8Pemetrexed 8Sorafenib 7Rituximab 7Cetuximab 7fludarabine 6Temozolomide 6Taxes 6Radiotherapy 6Leucovorin 6Fluorouracil 6Azacitidine 6Ascorbic Acid 6lenvatinib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Neoplasms × Sunitinib × Clear all
NCT00463060 2018-07-18

Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer

Icahn School of Medicine at Mount Sinai

Phase 1/2 Completed
47 enrolled 18 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡